Valeant Pharmaceuticals ( VRX) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. Valuation call, based on a $54 price target. WellPoint ( WLP) downgraded at Jefferies to Hold from Buy, Jefferies said. $72 price target. Company miss will decrease target multiple.
STOCK COMMENTS / EPS CHANGES
Boeing ( BA) estimates lowered at Citigroup through 2013, Citigroup said. Outlook for defense business is not as robust as originally forecast. Maintain Buy rating and $87 price target. Peabody Energy ( BTU) numbers lowered at Goldman. Shares of BTU now seen reaching $41, according to Goldman Sachs. Estimates also cut, given higher spending on Macarthur. Neutral rating. Delta Air Lines ( DAL) numbers raised at UBS. Shares of DAL now seen reaching $15. Estimates also increased on strong outlook. Buy rating. Dover ( DOV) estimates, target upped at Credit Suisse. DOV estimates were boosted through 2013, Credit Suisse said. Booking are stabilizing. Neutral rating and new $67 price target. Corning ( GLW) numbers cut at UBS. Shares of GLW now seen reaching $15, according to UBS. Estimates also lowered as near term catalysts remain elusive and fundamentals remain difficult. Buy rating. WW Grainger ( GWW) numbers boosted at Goldman. Shares of GWW now seen reaching $211, Goldman Sachs said. Estimates also upped, Revenue growth is accelerating. Neutral rating. Hess ( HES) estimates, target reduced at Goldman. HES estimates were cut through 2015, Goldman Sachs said. Company is facing higher costs. Neutral rating and new $66 price target. Hess estimates, target lowered at UBS. Shares of HES now seen reaching $68, according to UBS. Estimates also lowered on 4Q miss and disappointing guidance. Buy rating. Illumina ( ILMN) target raised at UBS to $55 following Roche's hostile bid, UBS said. Maintain Neutral rating. McDonald's ( MCD) estimates, target raised at BMO. Shares of MCD now seen reaching $110, according to BMO Capital. Estimates also increased, given solid comp sales momentum. Market Perform rating. Molex ( MOLX) estimates, target cut at Goldman. Shares of MOLX now seen reaching $24.50, according to Goldman Sachs. Estimates also reduced, as the company is realizing lower margins. Neutral rating. Netflix ( NFLX) numbers raised at Oppenheimer. Shares of NFLX now seen reaching $130, Oppenheimer said. Estimates also raised on better than expected results. Outperform rating.